Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

Mirum Pharmaceuticals, Inc. today announced that it will present data at three upcoming medical congresses. Digestive Disease Week (DDW) will be held in San Diego, May 3-6, 2025. The European ...

Itchy skin, or pruritus, can be a symptom of liver disease. However, not everyone with liver disease experiences itching, and the specific causes of this itching are unknown. Treatment for itching ...

Designing studies around endpoints that truly matter to patients As Mirum’s portfolio has expanded — potentially moving into larger indications like primary sclerosing cholangitis (PSC ...

TNF ligand superfamily member 12, CD6 isoform, and chemokine ligand 20 were associated with a higher risk of primary sclerosing cholangitis. The researchers also showed, using reverse magnetic ...

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...

The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC). There is a strong association ...

Apr. 8—Ohio's 2025 primary election is slated for May 6, with early voting underway. Registered voters in Ohio can weigh in on a statewide issue that will appear on all ballots. County ...

Ipsen has announced that its Iqirvo (elafibranor) tablets have been accepted by the Scottish Medicines Consortium (SMC) to treat adults with the rare cholestatic liver disease primary biliary ...

The Republican Party in Virginia confirmed on Saturday that the commonwealth’s lieutenant governor, Winsome Earle-Sears, will be the party’s primary nominee in the 2025 gubernatorial race.

Objective Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this ...

Seladelpar, a medication developed by Gilead, has received conditional approval for the treatment of primary biliary cholangitis (PBC), an autoimmune disease affecting the liver. This condition leads ...